loader

World Tenders & Procurement Opportunities

323156- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient carglumic acid, ATC A16AA05, for the period from July 1, 2025, to June 30, 2027 (plus an extension option of 12 months).

World Biggest Tenders Source

This tender with title 323156- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient carglumic acid, ATC A16AA05, for the period from July 1, 2025, to June 30, 2027 (plus an extension option of 12 months). has been published on Bidding Source portal dated 22 May 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

323156- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient carglumic acid, ATC A16AA05, for the period from July 1, 2025, to June 30, 2027 (plus an extension option of 12 months).
Invitation for Bids
323156
Germany
22 May 2025
5 May 2028
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

324018- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient epinephrine, ATC C01CA24, for the period from July 1, 2025, to June 30, 2027 (plus an extension option of 12 months). Germany 322835- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient lenalidomide, ATC L04AX04, for the period from July 1, 2025, to June 30, 2027 (plus an extension option of 12 months). Germany 322504- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient cyanocobalamin, ATC B03BA01, for the period from July 1, 2025, to June 30, 2027 (plus extension option 1x 12 months) Germany 325189- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient Cabotegravir, ATC J05AJ04 for the period 01.07.2025 - 30.06.2027 Germany 325033- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Somatropin, ATC H01AC01 for the period 01.07.2025 - 30.06.2027 Germany 324927- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient Fremanezumab, ATC N02CD03 for the period 01.07.2025 - 30.06.2027 Germany 324718- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient Lamivudine + Abacavir + Dolutegravir, ATC J05AR13 for the period 01.07.2025 - 30.06.2027 Germany 324446- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Golimumab, ATC L04AB06 for the period 01.07.2025 - 30.06.2027 Germany 324289- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient sapropterin (exclusively dosage form PLE), ATC A16AX07 for the period 01.07.2025 - 30.06.2027 Germany 323588- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient rilpivirine, ATC J05AG05 for the period 01.07.2025 - 30.06.2027 Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans